Three independent discounted-cash-flow-style models value Avanos Medical Inc every trading day. 0 of 3 currently price AVNS above its market price.
| Free Cash Flow model | $-8.93 |
| Excess Profit model | $-5.03 |
| Residual Earnings model | $-2.52 |
| Dividend Discount model | — |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +1.3% |
| Net debt / EBITDA | 0.8× |
| Gross margin | +50.5% |
| Revenue CAGR | +0.8% |
| Cash conversion | — |
| Dividend yield | — |
| Buyback yield | +0.5% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open AVNS in StockKitty